Hamburg, Germany

Patrick Ziegelmuller

This inventor holds 1 USPTO granted patent. Top assignee: Georgetown University. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Ziegelmuller

Introduction

Patrick Ziegelmuller is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of biochemistry, particularly through his innovative work on protease-derivatized cobra venom factor.

Latest Patents

Ziegelmuller holds a patent for a novel functionally active derivative of cobra venom factor. This patent, titled "Protease-derivatized CVF," describes a process in which the beta-chain of the cobra venom factor has been cleaved by treatment with a protease. Gel electrophoretic analyses of the purified derivative revealed the absence of an intact beta-chain and a decrease in molecular weight. He has 1 patent to his name.

Career Highlights

Patrick Ziegelmuller is affiliated with Georgetown University, where he continues to advance his research and innovation in biochemistry. His work has garnered attention for its potential applications in various fields, including medicine and pharmacology.

Collaborations

Ziegelmuller has collaborated with esteemed colleagues such as Thomas Grunwald and Markus W Ollert. These partnerships have contributed to the depth and impact of his research.

Conclusion

Patrick Ziegelmuller exemplifies the spirit of innovation in the scientific community. His work on protease-derivatized cobra venom factor showcases his commitment to advancing biochemistry and its applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…